{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:43:44Z","timestamp":1791200624368,"version":"4.2.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.cyto.2009.09.007","type":"journal-article","created":{"date-parts":[[2009,10,16]],"date-time":"2009-10-16T08:31:05Z","timestamp":1255681865000},"page":"185-193","source":"Crossref","is-referenced-by-count":154,"title":["The Th17\/Treg functional imbalance during atherogenesis in ApoE\u2212\/\u2212 mice"],"prefix":"10.1016","volume":"49","author":[{"given":"Jiang-jiao","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-ting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-yang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-hua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2009.09.007_bib1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2009.09.007_bib2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2009.09.007_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.RES.0000029784.15893.10","article-title":"Innate and adaptive immunity in the pathogenesis of atherosclerosis","volume":"91","author":"Hansson","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.cyto.2009.09.007_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frostegard","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2009.09.007_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.yjmcc.2008.04.003","article-title":"Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE(\u2212\/\u2212) mice through modulation of Th1\/Th2 balance","volume":"45","author":"Cheng","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cyto.2009.09.007_bib6","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.jacc.2005.03.040","article-title":"Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes","volume":"45","author":"Methe","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cyto.2009.09.007_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10875-005-4088-0","article-title":"TH1\/TH2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation","volume":"25","author":"Cheng","year":"2005","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.cyto.2009.09.007_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cyto.2009.09.007_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"T (H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2009.09.007_bib10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00105-006-1199-3","article-title":"After TH1\/TH2 now comes Treg\/TH17: significance of T helper cells in immune response organization","volume":"57","author":"Homey","year":"2006","journal-title":"Hautarzt"},{"key":"10.1016\/j.cyto.2009.09.007_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cyto.2009.09.007_bib12","doi-asserted-by":"crossref","unstructured":"de Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, van der Wal AC. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesion. PLos ONE 2007;2:e779:1\u20137.","DOI":"10.1371\/journal.pone.0000779"},{"key":"10.1016\/j.cyto.2009.09.007_bib13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E","volume":"258","author":"Zhang","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.cyto.2009.09.007_bib14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.ATV.0000259365.31469.89","article-title":"Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis","volume":"27","author":"Mor","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cyto.2009.09.007_bib15","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.0000038140.80105.AD","article-title":"Antimonocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice","volume":"106","author":"Inoue","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2009.09.007_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0021-9150(87)90202-4","article-title":"Quantitative assessment of atherosclerotic lesions in mice","volume":"68","author":"Paigen","year":"1987","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2009.09.007_bib17","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1161\/01.CIR.103.16.2096","article-title":"New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockoutmice","volume":"103","author":"Ni","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2009.09.007_bib18","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","article-title":"IFN-gamma potentiates atherosclerosis in apoE knock-out mice","volume":"99","author":"Gupta","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2009.09.007_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2009.09.007_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4049\/jimmunol.156.1.5","article-title":"Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)","volume":"156","author":"Ferber","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2009.09.007_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI0215751","article-title":"Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12","volume":"110","author":"Becher","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2009.09.007_bib22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2009.09.007_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2009.09.007_bib24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.mca.0000236288.94553.b4","article-title":"Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary disease","volume":"17","author":"Hashmi","year":"2006","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.cyto.2009.09.007_bib25","doi-asserted-by":"crossref","unstructured":"Michon I, De Vos P, Van Wanrooij E, Van Berkel T, Kuiper J. Division of biopharmaceutics, Netherlands. The role of IL-17 in atherosclerotic lesion formation in mice. In: Thirteenth international symposium on atherosclerosis, 28 September\u20132 October 2003. Kyoto, Japan [abstract].","DOI":"10.1016\/S1567-5688(03)91343-2"},{"key":"10.1016\/j.cyto.2009.09.007_bib26","unstructured":"Michon IN, De Vos P, Peterse N, Van Berkel TJC, Kuiper J. Biopharmaceutics. In: Activation of macrophages by IL-15 and IL-17 in atherosclerotic lesion development. LACDR: University Leiden, Leiden, Netherlands. ICI\/FOCIS 2004 [abstract]."},{"key":"10.1016\/j.cyto.2009.09.007_bib27","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.mehy.2004.03.009","article-title":"Synergistic effects of vascular IL-17 and TNF-alpha may promote coronary artery disease","volume":"63","author":"Csiszar","year":"2004","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.cyto.2009.09.007_bib28","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1189\/jlb.0109006","article-title":"All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg\/Th17 profile in human ulcerative and murine colitis","volume":"86","author":"Bai","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cyto.2009.09.007_bib29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0896-8411(03)00121-5","article-title":"Quantification of regulatory T cells in patients with systemic lupus erythematosus","volume":"21","author":"Crispin","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cyto.2009.09.007_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI0213605","article-title":"Multiple immuno-regulatory defects in type-1 diabetes","volume":"109","author":"Kukreja","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2009.09.007_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF-alpha therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2009.09.007_bib32","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2009.09.007_bib33","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1093\/eurheartj\/ehl222","article-title":"Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes","volume":"27","author":"Mor","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cyto.2009.09.007_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clim.2007.03.546","article-title":"The opposite-direction modulation of CD4+ CD25+ Treg and T helper1 cells in acute coronary syndromes","volume":"124","author":"Han","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cyto.2009.09.007_bib35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.cyto.2009.09.007_bib36","first-page":"359","article-title":"Evidence for a local immune response in atherosclerosis: CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice","volume":"149","author":"Zhou","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2009.09.007_bib37","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1096\/fj.01-0463com","article-title":"Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans","volume":"15","author":"Moghadasian","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.cyto.2009.09.007_bib38","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1172\/JCI200423395","article-title":"CD4+ Tregs and immune control","volume":"114","author":"Fehervari","year":"2004","journal-title":"J Clin Invest"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346660900828X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346660900828X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T05:53:34Z","timestamp":1685166814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346660900828X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S104346660900828X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2009.09.007","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}